Immunotherapy

We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma.

A peculiar type of tumour, in an even more peculiar type of animal, could hold some clues to help scientists overcome immunotherapy resistance in humans.

In this Science Surgery post Millie asks: ‘Why doesn’t the immune system attack cancer cells?’ The short answer is it does! But sometimes it needs a helping hand from exciting new treatments.

With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.

Dr James Allison and Professor Tasuku Honjo have been given a Nobel Prize for revolutionising our understanding of how the immune system sees cancer.

In this Science Surgery post we explore the work being done to use existing treatments in other types of cancer.

We spoke to Professor Margaret Frame, from the Cancer Research UK Edinburgh Centre, about her OBE for her contribution to cancer research.

Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time.

This week saw new research on brain tumour and ovarian cancers, while MPs launched an inquiry into e-cigarettes.

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.